Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-25
DOI
10.1007/s00415-019-09395-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: A Network Meta-Analysis
- (2018) Rosa C. Lucchetta et al. CNS DRUGS
- Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
- (2018) Bernard M. J. Uitdehaag CNS DRUGS
- ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) X. Montalban et al. EUROPEAN JOURNAL OF NEUROLOGY
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis
- (2018) Alexander Rae-Grant et al. NEUROLOGY
- Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis
- (2018) Alexander Rae-Grant et al. NEUROLOGY
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Deciding on the Best Multiple Sclerosis Therapy
- (2018) Joseph R. Berger et al. JAMA Neurology
- Update on disease-modifying therapies for multiple sclerosis
- (2017) Diana L Vargas et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Evolving concepts in the treatment of relapsing multiple sclerosis
- (2017) Giancarlo Comi et al. LANCET
- Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis
- (2016) Emer Fogarty et al. Multiple Sclerosis and Related Disorders
- New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis
- (2015) Clayton English et al. CLINICAL THERAPEUTICS
- Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
- (2014) P. Browne et al. NEUROLOGY
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
- (2011) Alasdair J Coles et al. LANCET NEUROLOGY
- MHC transmission: Insights into gender bias in MS susceptibility
- (2011) M. J. Chao et al. NEUROLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now